Another Follow-up Test, ME/CFS

Prior posts for this person are linked below

I am going to review using the traditional analysis. My initial impression is that suggested retesting and plotting the next course correction was missed. As with sailing a boat, this can sail a person to an unintended spot. The last section is trying some work in progress on his sample(s). This is experimental work which I have high hope on yielding much finer identification of the critical bacteria that should be addressed.

Analysis

My usual starting point for multiple tests is compare forecasts of symptoms: New sample is 2025-11, old sample is 2025-03. Things have gotten worse.

I decide to compare 2025-11 to 2024-12 and see the latest sample is still worse, but not as bad. In other words, the gains made over the summer has been lost. This person is in a northern climate so seasonal variation could (theoretically) be significant.

As often, we have a high hit rate of projected symptoms against actual symptoms.

Current Back Story

The first line is reflected above.

I have not been feeling so well lately (since the last year).

I would say that my symptoms has become worse.

Earlier it has always felt as I have done some progress but the last 12 months it has been the opposite. 

Earlier I got rid of my muscle and joint pain but it has come back and I have much bigger issues with my red nose and my body feels very stressed.

Also feel very bloated.

A summary of my biggest issues:

  • Get the red nose (some form of rosacea). 
  • Feel fatigued (both physically and mentally). 
  • Feeling stressed. 
  • Brain fog.
  • Bloated.
  • Lots of gas – I fart and burps a lot. 
  • Issues with allergies
  • Muscle and joint pain

For the last 4 years I’ve been eating large amounts of rye and oats.

Around 150-200 gram of rye bread every day.

Around 70 gram of oats every day.

Been eating low fat, low protein and high carb (specially from rye, oats, apple juice and potatoes) because this diet seem to reduce my symptoms.

As soon as I start to eat high meat and high fat my symptoms get worse.

Traditional Analysis

First, I am doing the “traditional” analysis before exploring some work in progress to improve suggestions further. The process is simple, pick Beginner-Symptoms, mark symptoms and get suggestions. This is the process that seems to produce the best results. Other choices are intended to satisfy people with different assumptions. The site purpose is allow people to use the data according to their beliefs about the best way.

Despite having 42 symptoms entered, this boiled down to just 20 bacteria. Many related symptoms are connected to the same bacteria.

Investigate: “As soon as I start to eat high meat and high fat my symptoms”

Looking at the consensus report we see:

Which agrees with his reported response. On the other side, generic “fat” is a significant plus– so the type of fat seems to be critical.

Investigate Current Eating Habits: eating large amounts of rye and oats.

The suggestions are intended to be course corrections for the microbiome. Keeping on a course for too long may end up running aground on mudflats (instead of the original reefs that the course correction was intended for).

The question is why rye is ok and other grains are not? It may be due to some composition aspect or a side-effect of having sparse data. It looks like some change of diet is suggested.

The positive food items appear to be:

  • fruit: grapes, especially lingonberries, cranberries (and likely cloudberries!), citric fruits, bananas
  • fish: fish oil,
  • legumes: beets, nuts, Asparagus, Rhubarb but NOT Pulses, Beans
  • Quinoa – which unlike cereals above is gluten free

Vitamins

The list is pretty short.

  • To take: Vitamin B6,7 and 12 but no other B vitamins (i.e. no mixtures)
  • Iron and Vitamin D are fine

Probiotics

There are two approaches here.

  • Using PubMed Studies only (sparse data, negative impacts almost never published)
  • Using Inference from Microbiome Taxa R2 Site.
  • A third way is in the next section with is like the R2 site, but using a 16s Biomesight reference set instead of a shotgun.

PubMed Studies

The top ones, in descending order are (with strike thru on ones that are hard to obtain):

Microbiome Taxa R2 Site

We end up with just 2 “safe” (positive impact only)

This leaves only one with 100% consensus: E.Coli (Mutaflor, Symbioflor-2). Looking at PubMed with a net positive with R2, we also have

My Own Experience

While fighting ME/CFS, I retested about 6 weeks after getting the results of the last test. I noticed that suggestions swing back and worth a lot – but I kept following them. Often there can be a battle between “common sense beliefs” and what the algorithms find. Avoiding something during one cycle and then taking it the next cycle seemed “irrational”. I borrowed from physical processes the concept of “microbiome oscillations” and stopped worrying about the swings.

My personal advice is simple, get results and then do suggestions for 6-8 week and do another test. With test processing delays, it means about 10-12 weeks on each set of suggestions

Going Forward — and a new Algorithm

Recently I have been working on an Odds Ratio investigation. The reason is simple, the Odds ratio gives an objective measure of the importance of each bacteria for the symptoms. The new approach uses Odds Ratio to determine the odds of a bacteria causing a symptom. The odds tells me the importance. If you are interested in more technical data, see:

I will be trying it out on his data. The databases involved are about 160GB with processing often taking 20 minutes for each processing state, so they are on my “garage” high performance server (nerd talk: 64GB of memory, fast M.2 NVMe  2TB drive for disk) and strictly for research/exploration at the moment.

Key differences

  • we are going to estimate symptoms a different way than traditional (using odds)
  • we are likely to have 100+ bacteria to shift

Predicted Symptoms Rank Order

Using the Odds Ratio approach we get the following predictions that agrees with his reported symptoms/characteristics.

Symptom NameStrength
Age: 30-4011.2
Sleep: Unrefreshed sleep10.9
Comorbid: Small intestinal bacterial overgrowth (SIBO)9.1
Immune Manifestations: Inflammation (General)9
General: Fatigue9
DePaul University Fatigue Questionnaire : Tingling feeling8.8
Neuroendocrine: Cold limbs (e.g. arms, legs hands)8.5
Neuroendocrine Manifestations: cold extremities8.3
Neurocognitive: Brain Fog8.1
Post-exertional malaise: Worsening of symptoms after mild mental activity8
DePaul University Fatigue Questionnaire : Fatigue7.9
Gender: Male7.9
DePaul University Fatigue Questionnaire : Muscle Pain (i.e., sensations of pain or aching in your muscles. This does not include weakness or pain in other areas such as joints)7.8
Immune Manifestations: Bloating7.5
DePaul University Fatigue Questionnaire : Allergies7.4
DePaul University Fatigue Questionnaire : Muscle weakness6.9
DePaul University Fatigue Questionnaire : Post-exertional malaise, feeling worse after doing activities that require either physical or mental exertion6.7
DePaul University Fatigue Questionnaire : Rash6.5
Post-exertional malaise: Mentally tired after the slightest effort6.3
Comorbid: Histamine or Mast Cell issues6.3
Post-exertional malaise: Next-day soreness after everyday activities6
Post-exertional malaise: Muscle fatigue after mild physical activity6
Official Diagnosis: Mast Cell Dysfunction5.9
Neuroendocrine Manifestations: worsening of symptoms with stress.5.9
Post-exertional malaise: Worsening of symptoms after mild physical activity5.8
DePaul University Fatigue Questionnaire : Does physical activity make you feel worse5.7
DePaul University Fatigue Questionnaire : Unrefreshing Sleep, that is waking up feeling tired5.7
Immune: Flu-like symptoms5.7
DePaul University Fatigue Questionnaire : Pain in Multiple Joints without Swelling or Redness5.5
Neurological-Audio: hypersensitivity to noise5.2
Immune Manifestations: Inflammation of skin, eyes or joints5.1

Looking at the existing estimates, we see far greater separation in weight/estimates. I favor separation because that implies much better focus on bacteria.

  1.  DePaul University Fatigue Questionnaire : Pain in Multiple Joints without Swelling or Redness ✅ – [83.2%]
  2.  DePaul University Fatigue Questionnaire : Muscle weakness ✅ – [83.1%]
  3.  Neuroendocrine Manifestations: cold extremities ✅ – [83.1%]
  4.  Neurocognitive: Brain Fog ✅ – [82.7%]
  5.  DePaul University Fatigue Questionnaire : Muscle Pain (i.e., sensations of pain or aching in your muscles. This does not include weakness or pain in other areas such as joints) ✅ – [82.7%]
  6.  Post-exertional malaise: Worsening of symptoms after mild physical activity ✅ – [82.4%]
  7.  Post-exertional malaise: Next-day soreness after everyday activities ✅ – [82.3%]
  8.  General: Fatigue ✅ – [82.3%]
  9.  Sleep: Unrefreshed sleep ✅ – [82.2%]
  10.  Comorbid: Small intestinal bacterial overgrowth (SIBO) ✅ – [82.1%]
  11.  Immune Manifestations: Bloating ✅ – [81.9%]
  12.  DePaul University Fatigue Questionnaire : Fatigue ✅ – [81.7%]
  13.  Official Diagnosis: Chronic Fatigue Syndrome (CFS/ME) ✅ – [81.5%]
  14.  Neurological-Audio: hypersensitivity to noise ✅ – [81.5%]
  15.  DePaul University Fatigue Questionnaire : Unrefreshing Sleep, that is waking up feeling tired ✅ – [81.4%]
  16.  DePaul University Fatigue Questionnaire : Difficulty staying asleep ✅ – [81.3%]
  17.  Official Diagnosis: Autoimmune Disease ✅ – [81.2%]
  18.  Immune Manifestations: Inflammation (General) ✅ – [81.2%]
  19.  DePaul University Fatigue Questionnaire : Easily irritated – [81.2%]
  20.  Neuroendocrine Manifestations: worsening of symptoms with stress. ✅ – [81.2%]

Key Bacteria identified

The new approach identifies these bacteria to target, with their relative importance (Weight). I just did another post on a ME/CFSer, Microbiome Interpretation – Questions From A User. Megamonas also was her top one.

tax nametax rankWeightTarget
Megamonasgenus108.9Too High
Klebsiella oxytocaspecies95.8Too High
Ruminococcus bromiispecies-17.9Too Low
Eubacterialesorder-16.1Too Low
Clostridiaclass-15.1Too Low
Megamonas funiformisspecies15Too High
Bacillotaphylum-14.2Too Low
Ruminococcaceaefamily-14.2Too Low
Segatellagenus13.6Too High
Oscillospiraceaefamily-13.4Too Low
Ruminococcusgenus-12.4Too Low
Terrabacteria groupclade-12.4Too Low
Segatella coprispecies11.9Too High
Bacteroidiaclass11.4Too High
Bacteroidalesorder11.4Too High
Bacteroidota/Chlorobiota groupclade10.3Too High
Bacteroidotaphylum10.1Too High
FCB groupclade9.8Too High
Prevotellagenus9.7Too High
Lachnospiraceaefamily-9.3Too Low
Prevotellaceaefamily9Too High
Phocaeicola vulgatusspecies8.4Too High
Akkermansiaceaefamily6.7Too High
Bacteroides uniformisspecies6Too High
Pseudomonadotaphylum5.9Too High
Gammaproteobacteriaclass5.2Too High
Yersiniagenus4.8Too High
Verrucomicrobiotaphylum4.3Too High
Akkermansiagenus4.1Too High
Verrucomicrobialesorder4Too High

The traditional approach identifies the list below. There is relatively little overlap. My ‘gut’ reading is that those above are likely a better candidate set than those below.

BacteriaRankShift
ThiotrichalesorderHigh
SharpeagenusHigh
SelenomonasgenusHigh
RuminococcusgenusHigh
NegativicutesclassLow
JohnsonellagenusHigh
HoldemaniagenusHigh
ErysipelothrixgenusHigh
DoreagenusHigh
DesulfovibrioniaclassLow
delta/epsilon subdivisionscladeLow
CyanophyceaeclassLow
Cyanobacteriota/Melainabacteria groupcladeLow
CoprococcusgenusHigh
ChlorobiotaphylumHigh
ChlorobiiaclassHigh
ChlorobiaceaefamilyHigh
ChlorobaculumgenusHigh
ActinomycetotaphylumLow
ActinomycetesclassLow

Suggestions

Since two bacteria dominates, I ran the suggestion algorithm only on those two bacteria. The results are below and very similar to the results from the traditional approach. “All algorithms lead to the same suggestions”. Doing the full list cited above, produced very similar suggestions.

ModifierNet
fruit/legume fibre263
fruit241
Fiber, total dietary217
Chitosan217
Slow digestible carbohydrates. {Low Glycemic}210
oolong teas205
polyphenols203
resveratrol-pterostilbene x Quercetin  {quercetin x resveratrol}202
(2->1)-beta-D-fructofuranan {Inulin}201
3,3′,4′,5,7-pentahydroxyflavone {Quercetin}200
High-fibre diet {Whole food diet}199
Citrus limon  {Lemon}194
 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine}193
Lonicera periclymenum {Epazote}184
Grape Polyphenols {Grape Flavonoids}177
tea177
dietary fiber169
red wine168
grapes163
Linum usitatissimum {Flaxseed}160
Lactobacillus plantarum {L. plantarum}158
Camellia Linnaeus {camellia}158
Coffee150
Hydrastis canadensis {Goldenseal}148
Ethanoic acid {Vinegar}148
Ulmus rubra {slippery elm}145
Ligilactobacillus salivarius {L. salivarius}144
Ginkgo biloba {Ginkgo}139
Cola aspartame {Diet Cola}138
pseudo-cereals  {amaranth,quinoa, taro,buckwheat}137
Agaricus bisporus {White button mushrooms}134
Theobroma cacao {Cacao}131
Caffeine127
Lacticaseibacillus rhamnosus {l. rhamnosus}124
fucoidan {Brown Algae Extract}122
Litchi chinensis {lychee fruit}121
coptis chinensis {Chinese goldthread }121

Probiotics using R2

First I used only the top two bacteria to see what is suggested with a very targeted set.

  • Bacillus subtilis 75
  • Lactobacillus jensenii 60

Below are pushing the full set of identified bacteria through BiomeSight R2 matrix, then filtered to positive impact with no risk. Escherichia coli (cited above) continues to be a take. Bacillus subtilis would be my fall back suggestion for a probiotic. It is marginally negative on the consensus report and not cited on other R2 suggestion list. For others candidates

  • Lactobacillus jensenii was one for and no comment
  • Lactococcus lactis is a one for and one against
  • Lactobacillus helveticus is one strong against and no comment
  • Lacticaseibacillus casei is one strong against and no comment
  • Akkermansia muciniphila is two strong avoid

I tend to do a variation of the traditional “Do no harm”, minimize the risk of adverse shifts.

ProbioticNet ImpactGood CountBad Count
Bacillus subtilis81.950
Lactobacillus jensenii68.520
Lactococcus lactis26.820
Lactobacillus helveticus21.440
Lacticaseibacillus casei21.420
Segatella copri21.230
Lactiplantibacillus pentosus2150
Akkermansia muciniphila18.740
Bacillus amyloliquefaciens group18.310
Enterococcus faecium16.310
Limosilactobacillus fermentum13.610
Heyndrickxia coagulans13.430
Enterococcus durans12.420
Pediococcus acidilactici1110
Enterococcus faecalis10.620
Leuconostoc mesenteroides10.510
Escherichia coli4.330

Bottom Line

The purpose of this post was to evaluate suggestions for a regular reader. The secondary goal was to see how well a new approach that I am developing is working. This new approach produces different targeted bacteria with very similar suggestions generated, the most significance difference is far more targeted probiotics for the symptoms based on the same lab data.

The one interesting aspect is that the key bacteria (just 2) were clearly identified. These two bacteria alone produced suggestions similar to the bigger bacteria selection. I do like this narrow bacteria selection of key bacteria and will likely do a few more samples to further explore things.

Follow Up

I decided to look at all of his samples with the new algorithm to look for patterns. Megamonas stands out as the one that most frequently appears and disappears. Klebsiella oxytoca and Morganellaceae are the next candidates.

Upload DateTop Bacteria
2021-09-24Megamonas genus 108.9 Too High
Lachnospiraceae family -56.2 Too Low
Eubacteriales order -47.3 Too Low
Bacillota phylum -46.6 Too Low
Clostridia class -46.4 Too Low
Terrabacteria group clade -44.8 Too Low
2021-09-24 Bacillota phylum -46.5 Too Low
Eubacteriales order -45.1 Too Low
Terrabacteria group clade -45 Too Low
Clostridia class -44.1 Too Low
Lachnospiraceae family -43.6 Too Low
2022-04-19 Klebsiella oxytoca species 95.8 Too High
Morganellaceae family 91 Too High
2022-09-04 Oscillospiraceae family 17.7 Too High
Ruminococcaceae family 17.4 Too High
Bacteroidaceae family -16 Too Low
Bacteroides genus -15.9 Too Low
2023-03-15 Megamonas genus 108.9 Too High
Lachnospiraceae family -26 Too Low
2023-09-26 Megamonas genus 108.9 Too High
2024-02-13 Bacteroidaceae family -27.3 Too Low
Bacteroides genus -27.3 Too Low
Phocaeicola dorei species -21.4 Too Low
2024-09-25 Segatella genus 13.6 Too High
Segatella copri species 11.9 Too High
2025-04-22Morganellaceae family 91.6 Too High
2025-12-08Megamonas genus 108.9 Too High
Klebsiella oxytoca species 95.8 Too High

Odds Ratio Snapshot: Restless Legs

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

In my weekly review, I noticed this new study: “Analysis of gut microbiota in Restless Legs Syndrome: searching for a metagenomic signature” Dec 2025 That identifies “a statistically significant decrease in the abundance of Lachnoclostridium and Flavonifractor genera in RLS compared to CTRL“. Just two bacteria. I was surprised to see so few reported. Below you will see my results (all all of the source data is available for download for those that wish to verify the numbers). I was able to get 137 significant shifts

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01137
p < 0.001126
p < 0.0001119
p < 0.00001103

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports). IMHO using average value instead of median will often result in a worse situation for the patient

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Bacteroidesgenus26.79726.01724.33728.038
Phocaeicolagenus10.59310.8529.36510.564
Bacteroides uniformisspecies2.922.7241.5552.385
Ruminococcusgenus6.6755.5764.3774.823
Clostridiumgenus2.0421.8551.361.803
Oscillospiragenus2.8982.3451.9522.313
Parabacteroidesgenus2.7412.6221.7232.016
Bacteroides cellulosilyticusspecies1.3590.8430.0750.312
Parabacteroides merdaespecies0.8230.7450.2980.531
Pedobactergenus1.050.9990.5530.742
Coprococcusgenus1.1931.4380.7350.558
Sutterellagenus1.3691.6511.2511.095
Roseburia faecisspecies1.2821.2050.5730.709
Novispirillumgenus0.8450.8660.0910.225
Insolitispirillumgenus0.8450.8670.0930.222
Insolitispirillum peregrinumspecies0.8450.8670.0930.222
Ruminococcus bromiispecies1.0150.7840.1690.292
Blautia coccoidesspecies0.7260.9150.5930.47
Caloramatorgenus1.0130.9370.1030.211
Blautia hanseniispecies1.191.0350.7170.824

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.

Nothing significant was found

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Streptococcus ursorisspecies0.0020.2621.69825
Actinopolymorphagenus0.0020.3517.415052
Actinopolymorpha rutilaspecies0.0020.3417.313847
Helicobacter suncusspecies0.0020.4713.1771363
Thermodesulfovibriogenus0.0020.4713.1627293
Desulfotomaculum defluviispecies0.0030.558.51037569
Bacteroides helcogenesspecies0.0020.448.58035
Bifidobacterium pullorumspecies0.0020.498.313968
Hydrogenophilusgenus0.0030.587.21162670
Pelagicoccusgenus0.0020.586.9850493
Sporotomaculum syntrophicumspecies0.0030.586.81134663

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Caldicellulosiruptorgenus0.0270.46279.525721189
Bifidobacterium longumspecies0.0122.23257.18911990
Hymenobacter xinjiangensisspecies0.0080.43239.61608696
Hymenobactergenus0.0080.47223.61832854
Thermicanusgenus0.1890.5211.122541135
Bifidobacterium gallicumspecies0.00352.21204.66541448
Anaerotruncus colihominisspecies0.1780.5320125321331
Bacteroides cellulosilyticusspecies0.3120.53191.224631311
Candidatus Glomeribactergenus0.0040.46179.21282592
Anaerotruncusgenus0.180.55170.624881379
Segatellagenus0.0161.8167.313472426
Staphylococcusgenus0.0040.43167.3943402
Erysipelothrixgenus0.01650.55167.222311220
Porphyromonasgenus0.0130.55165.721721185
Erysipelothrix murisspecies0.0150.55158.921861211
Clostridiumgenus1.8030.57158.325511454
Emticicia oligotrophicaspecies0.0070.54156.719441057
Caloramator uzoniensisspecies0.00650.51155.51416716
Emticiciagenus0.0070.5515419421062
Bifidobacterium choerinumspecies0.0051.86151.49271728

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

Per above, nothing was found

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Caldicellulosiruptorgenus0.0270.46279.525721189
Bifidobacterium longumspecies0.0122.23257.18911990
Hymenobacter xinjiangensisspecies0.0080.43239.61608696
Hymenobactergenus0.0080.47223.61832854
Thermicanusgenus0.1890.5211.122541135
Bifidobacterium gallicumspecies0.00352.21204.66541448
Anaerotruncus colihominisspecies0.1780.5320125321331
Bacteroides cellulosilyticusspecies0.3120.53191.224631311
Candidatus Glomeribactergenus0.0040.46179.21282592
Anaerotruncusgenus0.180.55170.624881379
Segatellagenus0.0161.8167.313472426
Staphylococcusgenus0.0040.43167.3943402
Erysipelothrixgenus0.01650.55167.222311220
Porphyromonasgenus0.0130.55165.721721185
Erysipelothrix murisspecies0.0150.55158.921861211
Clostridiumgenus1.8030.57158.325511454
Emticicia oligotrophicaspecies0.0070.54156.719441057
Caloramator uzoniensisspecies0.00650.51155.51416716
Emticiciagenus0.0070.5515419421062
Bifidobacterium choerinumspecies0.0051.86151.49271728

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic SpeciesImpactGood CountBad Count
Segatella copri52.2880
Bifidobacterium breve43.16170
Enterococcus faecalis37.793733
Bifidobacterium longum37.42180
Bifidobacterium adolescentis28.09170
Lactobacillus johnsonii20.642828
Lactobacillus helveticus14.22441
Blautia wexlerae13.6631
Bifidobacterium bifidum8.5110
Bifidobacterium catenulatum7.5990
Enterococcus faecium5.851218
Akkermansia muciniphila4.13821
Bifidobacterium animalis3.7670
Bacillus subtilis2.132021
Clostridium butyricum1.211011
Bifidobacterium pseudocatenulatum0.287
Ligilactobacillus salivarius0.0525
Limosilactobacillus fermentum0.0497
Limosilactobacillus reuteri0.021117
Enterococcus durans-0.011814
Heyndrickxia coagulans-0.0156
Lactococcus lactis-0.0352
Veillonella atypica-0.04211
Leuconostoc mesenteroides-0.0657
Lactiplantibacillus pentosus-0.0613
Lactiplantibacillus plantarum-0.0714
Lacticaseibacillus rhamnosus-0.0705
Lacticaseibacillus casei-0.0816
Lactobacillus crispatus-0.1310
Lactobacillus acidophilus-0.3511
Limosilactobacillus vaginalis-0.471634
Streptococcus thermophilus-0.9214
Lactobacillus jensenii-1.131824
Odoribacter laneus-2.203
Pediococcus acidilactici-5.982328
Escherichia coli-28.64012
Parabacteroides goldsteinii-37.48019
Blautia hansenii-39.47419
Parabacteroides distasonis-42.8209
Faecalibacterium prausnitzii-239.335
Bacteroides uniformis-252.6127
Bacteroides thetaiotaomicron-284.92210

Microbiome Interpretation – Questions From A User

A reader wrote the following to me. This post and associate video is an attempt to answer.

When I compare my first two analyses from Biomesight under “Multiple Samples,” the distribution of bacteria improves toward normal—assuming that the reduction in “Lab Read Quality” from 39.3 to 23.5 does not mean that the latest sample is a false positive. I have read your article “Lab Quality Versus Bacteria Reported,” but I am too brain fogged to really understand the content. 

In fact, “Symptom Pattern Matching” states that there was only one improvement and 150 deteriorations. Subjectively, I feel differently, not really better, but not much worse either. That’s why I don’t know how to interpret these results. (Better: nausea, migraine, constipation—Worse: brain fog, fatigue, sleep, muscle strength. So, speculation that: MCAS is improving, but ME-CFS continues to progressively worsen).

The suggestions under “To Avoid” have changed under “Food.” It is interesting to note that, before I was aware of these suggestions, they were already reflected in my appetite or aversion to certain foods; so it is reassuring that my body perception actually corresponds to the measured facts and the statistically supported conclusions. 

Unfortunately, my subjective perception of a change, but not an improvement, would then also correspond with the “outside ranges” and “symptom pattern matching.” (Objectively, I measure heart rate variability, pulse, and temperature with a simple GARMIN device and thermometer.)

I don’t know enough about statistics and am not fully mentally present, so I would be grateful if you could provide a few assessments of the measured changes, if you have the time. 

https://youtu.be/JXP9UWQVU_A

Sample Comparison

With two or more samples, the ability to compare samples using symptom forecasts is intended to give a good indicator of change. In most cases, there is significant improvement. In this case, things became worse.

There can be many causes:

  • Catching a virus, food poisoning, etc between samples
  • Ignoring the “Avoids” – items that feed the bad bacteria
  • Trying to follow two sets of advice that have not been reconcilled
    • A health consultant and microbiome prescription suggestions.

“Feeling the same” with these minor shifts is not unexpected. Remembering how you were tend to be unreliable; bad memories fail fast.

Getting Suggestions is Easy, Picking Bacteria is not

Microbiome Prescription is constantly update on what influence bacteria from new studies every week. At present if has a 7,432,372 Modifier-to-Bacteria relationships in its database. Given a set of bacteria, their shifts and the relative importance of each bacteria, the suggestions are a relatively simple computation.

Picking Bacteria

If you go to the typical alternative health practitioners, or just ask on line, you may not need to get a microbiome tests. From your symptoms, they will speculate on the issue and give suggestions that they will swear works. In reality, they may appear to work because the patients that they worked for, will come back to see them again. For those where it does not work, they will move on to the next “expert”.

Testing labs will often provide a reference range for some bacteria and thus identify if you have too much or too low. There are many technical issues using these. Personally, I avoid using them — but to make people happy, several are provided on the site (Old UI).

The Simple UI gives a few canned choices for selecting the bacteria and then does the easy part, computing suggestions. The numbers of bacteria vary greatly.

A new algorithm in development, identified 2 very critical bacteria (HIGH WEIGHT) and 20 minor bacteria. The goal of the new algorithm is to better pinpointing the key bacteria and their impact.to look

  • Both Samples had the same top item
    • Megamonas, genus, weight 109, too high on both tests
    • Morganellaceae, famiy, weight 92, too high on latest test only,

The addition of Morganellaceae in the latest sample may account for the worse report.

Going forward, I would look at what decreases these two bacteria. I ran your latest data through the suggestion algorithm and attach the full set of suggestions in excel.

The main take items from the new algorithm are below

  • Slow digestible carbohydrates. {Low Glycemic}
  • dietary fiber
  • Fiber, total dietary
  • fruit
  • fruit/legume fibre
  • High-fibre diet {Whole food diet}
  • Lactobacillus plantarum {L. plantarum}
  • (2->1)-beta-D-fructofuranan {Inulin}
  • oligosaccharides {oligosaccharides}
  • 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium {Berberine}
  • bacillus,lactobacillus,streptococcus,saccharomyces probiotic
  • 3,3′,4′,5,7-pentahydroxyflavone {Quercetin}
  • fucoidan {Brown Algae Extract}
  • Lacticaseibacillus rhamnosus {l. rhamnosus}
  • yogurt
  • grapes
  • polyphenols
  • Grape Polyphenols {Grape Flavonoids}
  • bacillus
  • bifidobacterium longum {B.Longum }
  • Linum usitatissimum {Flaxseed}
  • resveratrol-pterostilbene x Quercetin {quercetin x resveratrol}
  • ß-glucan {Beta-Glucan}
  • Saccharomyces cerevisiae var boulardii {S. boulardii}
  • Outer Layers of Triticum aestivum {Wheat Bran}
  • tea

Compared to the existing using symptoms. They are similar and both have top items of:

  • Lactobacillus plantarum
  • fruit
  • dietary fiber

Odds Ratio Snapshot: Photophobia (Light Sensitivity)

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01177
p < 0.001160
p < 0.0001138
p < 0.00001124

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Faecalibacterium prausnitzii is below, we see that the average is above and the median below.

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Faecalibacterium prausnitziispecies10.36612.27711.4159.08
Faecalibacteriumgenus10.88112.84312.1319.826
Lachnospiragenus2.4012.7381.91.418
Coprococcusgenus1.0711.4430.7370.428
Phocaeicola doreispecies2.6992.9160.4180.128
Parabacteroidesgenus2.3852.6341.7241.989
Clostridiumgenus2.0051.8541.3591.6
Roseburia faecisspecies0.9511.2150.5760.457
Bacteroides caccaespecies1.590.8520.2860.402
Mediterraneibactergenus0.8050.7130.2770.381
Bacteroides thetaiotaomicronspecies1.1041.0710.4630.561
Lachnospira pectinoschizaspecies0.5470.6670.3360.249
Bifidobacteriumgenus0.7610.940.1270.042
Bacteroides cellulosilyticusspecies1.3960.8360.0760.151
Blautia wexleraespecies0.8690.5690.3140.386
Bilophilagenus0.3430.350.210.278
Anaerotruncusgenus0.2840.1840.1360.203
Akkermansia muciniphilaspecies2.3981.3250.050.117
Akkermansiagenus2.3981.3250.0510.117
Anaerotruncus colihominisspecies0.2590.1730.1330.198

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below

tax_nameRankIncidence Odds RatioChi2Symptoms %Reference %
Actinobacillus porcinusspecies0.616.924.540.2
Slackia faecicanisspecies1.537.844.829.2
Mogibacterium vescumspecies1.7911.532.218

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

Psychrobacter glacialisspecies0.0020.3730.5664247
Niabellagenus0.0020.3927.4583226
Thermoanaerobacteriumgenus0.0020.424.4485195
Chromatiumgenus0.0020.4124.2508206
Chromatium weisseispecies0.0020.4124.1507206
Thermoanaerobacterium islandicumspecies0.0020.4123.6478195
Syntrophomonas sapovoransspecies0.0020.4222.5536226
Sporosarcina pasteuriispecies0.0020.4221.9440184
Thermodesulfovibrio thiophilusspecies0.0020.4321543236
Sporosarcinagenus0.0020.4320.6444191
Oenococcusgenus0.0020.4520.1609272
Thermodesulfovibriogenus0.0020.4519.5629285
Helicobacter suncusspecies0.0020.4718.3768361
Desulfofundulusgenus0.0020.4618.2496227
Herbaspirillum magnetovibriospecies0.0020.5113.6447226
Streptococcus infantisspecies0.0030.5412804437
Sphingomonasgenus0.0020.5311.9457242
Desulfotomaculum defluviispecies0.0030.5611.31022570
Alkalibacteriumgenus0.0030.5710.5906514
Hydrogenophilusgenus0.0030.5810.21149662

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Methylonatrumgenus0.0050.35374.21861655
Methylonatrum kenyensespecies0.0050.35374.21861655
Anaerotruncus colihominisspecies0.1980.41365.127121113
Anaerotruncusgenus0.2030.42340.326881141
Odoribacter denticanisspecies0.0060.412911856760
Luteolibactergenus0.0170.38245.61225468
Luteolibacter algaespecies0.0170.39240.41214468
Finegoldiagenus0.01150.41212.11210501
Anaerococcusgenus0.0120.4206.31099444
Eggerthella sinensisspecies0.0060.44197.21289568
Finegoldia magnaspecies0.0080.4195.41014408
Coprococcusgenus0.42851.87191.413792577
Desulfovibrio fairfieldensisspecies0.03950.4175.1868347
Mogibacteriumgenus0.0230.54170.421541159
Bifidobacteriumgenus0.042451.8169.213902505
Rubritaleagenus0.0040.43168.7969415
Bifidobacterium longumspecies0.0161.9167.69861876
Lysobactergenus0.0040.36164.9657236
Porphyromonasgenus0.0130.54164.721561174
Psychrobacter glacialisspecies0.0020.37158664247

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankSymptom Median FreqOdds RatioChi2BelowAbove
Clostridium taeniosporumspecies0.0030.68.61359821

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Methylonatrumgenus0.0050.35374.21861655
Methylonatrum kenyensespecies0.0050.35374.21861655
Anaerotruncus colihominisspecies0.1980.41365.127121113
Anaerotruncusgenus0.2030.42340.326881141
Odoribacter denticanisspecies0.0060.412911856760
Luteolibactergenus0.0170.38245.61225468
Luteolibacter algaespecies0.0170.39240.41214468
Finegoldiagenus0.01150.41212.11210501
Anaerococcusgenus0.0120.4206.31099444
Eggerthella sinensisspecies0.0060.44197.21289568
Finegoldia magnaspecies0.0080.4195.41014408
Coprococcusgenus0.42851.87191.413792577
Desulfovibrio fairfieldensisspecies0.03950.4175.1868347
Mogibacteriumgenus0.0230.54170.421541159
Bifidobacteriumgenus0.042451.8169.213902505
Rubritaleagenus0.0040.43168.7969415
Bifidobacterium longumspecies0.0161.9167.69861876
Lysobactergenus0.0040.36164.9657236
Porphyromonasgenus0.0130.54164.721561174
Psychrobacter glacialisspecies0.0020.37158664247

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic SpeciesImpactGood CountBad Count
Faecalibacterium prausnitzii434.7180
Bifidobacterium breve64.25170
Bifidobacterium longum57.5200
Bifidobacterium adolescentis42.25170
Bifidobacterium bifidum13.35122
Bifidobacterium catenulatum11.39110
Bifidobacterium animalis6.1470
Enterococcus faecium2.642325
Escherichia coli1.6758
Enterococcus faecalis1.375144
Limosilactobacillus reuteri0.811617
Streptococcus thermophilus0.7340
Bacillus subtilis0.522832
Veillonella atypica0.592
Lactobacillus helveticus0.344644
Enterococcus durans0.32521
Lactococcus lactis0.2261
Heyndrickxia coagulans0.121011
Lacticaseibacillus paracasei-0.0236
Lactiplantibacillus pentosus-0.0222
Lactiplantibacillus plantarum-0.0635
Bifidobacterium pseudocatenulatum-0.081913
Lacticaseibacillus rhamnosus-0.0924
Lacticaseibacillus casei-0.1337
Leuconostoc mesenteroides-0.24411
Ligilactobacillus salivarius-0.3219
Clostridium butyricum-0.41520
Odoribacter laneus-0.5503
Lactobacillus crispatus-0.65724
Lactobacillus acidophilus-1.02929
Segatella copri-1.142
Limosilactobacillus vaginalis-1.192545
Bacteroides thetaiotaomicron-2.2105
Bacteroides uniformis-2.7706
Lactobacillus jensenii-3.62251
Pediococcus acidilactici-19.952440
Blautia wexlerae-19.9932
Parabacteroides goldsteinii-22.17115
Akkermansia muciniphila-27.03226
Parabacteroides distasonis-35.63010
Blautia hansenii-39.03410
Lactobacillus johnsonii-41.553141

Odds Ratio Snapshot: Tinnitus (ringing in ear)

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01226
p < 0.001199
p < 0.0001176
p < 0.00001157

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides below, we see that the average is above and the median below.

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Bacteroidesgenus28.63325.84224.11427.576
Phocaeicola vulgatusspecies6.5935.7443.3474.644
Phocaeicolagenus11.77710.789.29110.397
Bacteroides uniformisspecies3.0312.7071.522.104
Parabacteroidesgenus2.5522.6311.7142.058
Bacteroides thetaiotaomicronspecies1.271.0560.4550.678
Clostridiumgenus2.0041.8471.3521.569
Oscillospiragenus2.452.3481.9442.144
Bacteroides cellulosilyticusspecies1.0320.840.070.237
Parabacteroides merdaespecies0.8540.7370.2870.44
Coprococcusgenus1.0711.4610.7390.59
Pedobactergenus1.2320.980.5480.695
Novispirillumgenus0.8160.8720.0870.229
Insolitispirillumgenus0.8160.8730.0890.229
Insolitispirillum peregrinumspecies0.8160.8730.0890.229
Bacteroides caccaespecies1.1350.8540.2810.38
Bifidobacteriumgenus0.5130.9690.1340.048
Bilophilagenus0.3950.3470.2060.276
Parabacteroides goldsteiniispecies0.5650.5710.130.194
Bilophila wadsworthiaspecies0.3760.3390.1970.256

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below

tax_nameRankIncidence Odds RatioChi2Symptoms %Reference %
Bifidobacterium catenulatumspecies0.698.325.236.2
Thiomonas thermosulfataspecies1.41829.420.9
Aggregatibactergenus0.657.81624.4
Desulfurispirillumgenus1.458.425.517.5
Desulfurispirillum alkaliphilumspecies1.458.125.217.4
Actinobacillus pleuropneumoniaespecies0.68.41118.5
Bifidobacterium cuniculispecies0.627.81219.3
Desulfonatronovibriogenus1.487.519.913.5
Erysipelothrix inopinataspecies1.477.419.913.5
Paraprevotella xylaniphilaspecies1.69.216.610.4
Candidatus Phytoplasma phoeniciumspecies1.598.71610.1
Trichodesmiumgenus1.566.612.98.3

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Alcanivoraxgenus0.0020.2675.237598
Isoalcanivoraxgenus0.0020.2674.536595
Isoalcanivorax indicusspecies0.0020.2674.536595
Nostoc flagelliformespecies0.0020.2767.331684
Salidesulfovibriogenus0.0020.363.2381115
Salidesulfovibrio brasiliensisspecies0.0020.363.2381115
Niabella aurantiacaspecies0.0020.3462.1524176
Mycoplasmopsis lipophilaspecies0.0020.2761.227775
Psychroflexusgenus0.0020.360.4348105
Psychroflexus gondwanensisspecies0.0020.360.4348105
Deferribacter autotrophicusspecies0.0020.3159.6374117
Pelagicoccus croceusspecies0.0020.3259.2380120
Deferribactergenus0.0020.3259377119
Psychrobacter glacialisspecies0.0020.3755.3636238
Thermodesulfatator atlanticusspecies0.0020.353.627683
Thermodesulfatatorgenus0.0020.353.627683
Segetibacter aerophilusspecies0.0020.3453.1364122
Bacillus ferrariarumspecies0.0020.3452.1356120
Niabellagenus0.0020.3851.8560212
Rickettsia marmionii Stenos et al. 2005species0.0020.3551.6379131

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Psychrobacter glacialisspecies0.0020.37150636238
Niabella aurantiacaspecies0.0020.34148.2524176
Desulfotomaculumgenus0.0040.51147.51394711
Alcanivoraxgenus0.0020.26145.837598
Isoalcanivoraxgenus0.0020.26142.836595
Isoalcanivorax indicusspecies0.0020.26142.836595
Niabellagenus0.0020.38132.4560212
Salidesulfovibriogenus0.0020.3127.5381115
Salidesulfovibrio brasiliensisspecies0.0020.3127.5381115
Bacteroides cellulosilyticusspecies0.2370.59127.222431325
Actinopolysporagenus0.0020.38125.5524198
Bifidobacteriumgenus0.0481.68125.313922332
Nostoc flagelliformespecies0.0020.27122.831684
Geobacillusgenus0.0030.43122.4672291
Bacteroides heparinolyticusspecies0.0030.49122.1928454
Erysipelothrix murisspecies0.0140.59121.620291195
Pelagicoccus croceusspecies0.0020.32120.7380120
Deferribacter autotrophicusspecies0.0020.31120.3374117
Deferribactergenus0.0020.32119.9377119
Psychroflexusgenus0.0020.3117.5348105

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankSymptom Median FreqOdds RatioChi2BelowAbove
Clostridium taeniosporumspecies0.0030.62161295805
Tetragenococcus doogicusspecies0.0030.6711.51316881
Dethiosulfovibriogenus0.0040.6711.31457981
Hydrocarboniphaga daqingensisspecies0.0040.718.715491096
Mycoplasmopsisgenus0.0050.72817091230

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Psychrobacter glacialisspecies0.0020.37150636238
Niabella aurantiacaspecies0.0020.34148.2524176
Desulfotomaculumgenus0.0040.51147.51394711
Alcanivoraxgenus0.0020.26145.837598
Isoalcanivoraxgenus0.0020.26142.836595
Isoalcanivorax indicusspecies0.0020.26142.836595
Niabellagenus0.0020.38132.4560212
Salidesulfovibriogenus0.0020.3127.5381115
Salidesulfovibrio brasiliensisspecies0.0020.3127.5381115
Bacteroides cellulosilyticusspecies0.2370.59127.222431325
Actinopolysporagenus0.0020.38125.5524198
Bifidobacteriumgenus0.0481.68125.313922332
Nostoc flagelliformespecies0.0020.27122.831684
Geobacillusgenus0.0030.43122.4672291
Bacteroides heparinolyticusspecies0.0030.49122.1928454
Erysipelothrix murisspecies0.0140.59121.620291195
Pelagicoccus croceusspecies0.0020.32120.7380120
Deferribacter autotrophicusspecies0.0020.31120.3374117
Deferribactergenus0.0020.32119.9377119
Psychroflexusgenus0.0020.3117.5348105

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic SpeciesImpactGood CountBad Count
Blautia hansenii92.34111
Bifidobacterium breve70.82173
Faecalibacterium prausnitzii67.96120
Bifidobacterium longum64.14190
Blautia wexlerae50.1360
Bifidobacterium adolescentis46.86150
Segatella copri39.4870
Enterococcus faecalis30.686031
Bifidobacterium bifidum14.43153
Lactobacillus helveticus13.524777
Bifidobacterium catenulatum13.5132
Escherichia coli12.84130
Enterococcus faecium7.352026
Bifidobacterium animalis6.5981
Lactobacillus johnsonii1.254046
Streptococcus thermophilus1.1730
Veillonella atypica0.9390
Bacillus subtilis0.853346
Clostridium butyricum0.742425
Enterococcus durans0.453623
Ligilactobacillus salivarius0.31211
Leuconostoc mesenteroides0.231712
Lactococcus lactis0.13511
Limosilactobacillus fermentum0.081012
Lacticaseibacillus paracasei-0.081228
Lacticaseibacillus casei-0.109
Heyndrickxia coagulans-0.222035
Lactiplantibacillus plantarum-0.2629
Bifidobacterium pseudocatenulatum-0.411835
Lactiplantibacillus pentosus-0.44822
Lactobacillus crispatus-0.46132
Lactobacillus acidophilus-0.521128
Lacticaseibacillus rhamnosus-0.6328
Lactobacillus jensenii-1.441941
Odoribacter laneus-1.5404
Limosilactobacillus vaginalis-1.793052
Limosilactobacillus reuteri-2.223146
Pediococcus acidilactici-6.82523
Akkermansia muciniphila-13.33232
Parabacteroides goldsteinii-41.6018
Parabacteroides distasonis-60.2507
Bacteroides uniformis-250.42011
Bacteroides thetaiotaomicron-261.55111

Odds Ration Snapshot: Bloating

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01202
p < 0.001173
p < 0.0001145
p < 0.00001129

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bacteroides uniformis below, we see that the average is above and the median below.

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Bacteroidesgenus27.63325.88424.12126.729
Bacteroides uniformisspecies2.9852.7051.5272.059
Novispirillumgenus0.7840.8760.0850.174
Insolitispirillumgenus0.7840.8770.0860.174
Insolitispirillum peregrinumspecies0.7840.8770.0860.174
Bacteroides cellulosilyticusspecies1.0240.8360.0730.151
Bilophilagenus0.3760.3480.2060.265
Bifidobacteriumgenus0.6070.9690.1310.072
Bilophila wadsworthiaspecies0.3650.3390.1960.255
Blautia obeumspecies0.6540.5630.2280.281
Hathewaya histolyticaspecies0.3180.2750.1540.188
Hathewayagenus0.3180.2750.1540.188
Lachnobacteriumgenus0.3270.320.0750.049
Anaerotruncusgenus0.2130.1840.1360.159
Bifidobacterium longumspecies0.2480.330.050.029
Oribacteriumgenus0.1230.1310.0740.053
Anaerotruncus colihominisspecies0.20.1730.1330.153
Oribacterium sinusspecies0.1160.1270.0720.053
Odoribactergenus0.1940.1970.1230.139
Megamonasgenus0.420.4390.0030.018

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below

tax_nameRankIncidence Odds RatioChi2Symptoms %Reference %
Prevotella biviaspecies1.429.526.919

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Alcanivoraxgenus0.0020.2777.836099
Isoalcanivoraxgenus0.0020.2777.334995
Isoalcanivorax indicusspecies0.0020.2777.334995
Niabella aurantiacaspecies0.0020.3469.1505172
Psychroflexusgenus0.0020.366.9345105
Psychroflexus gondwanensisspecies0.0020.366.9345105
Salidesulfovibriogenus0.0020.3265.7376120
Salidesulfovibrio brasiliensisspecies0.0020.3265.7376120
Deferribacter autotrophicusspecies0.0020.3265.4366116
Deferribactergenus0.0020.3264.5368118
Psychrobacter glacialisspecies0.0020.3862.5623237
Pelagicoccus croceusspecies0.0020.3262.3357116
Rickettsia marmionii Stenos et al. 2005species0.0020.3460.6372125
Bacillus ferrariarumspecies0.0020.3458.4350118
Niabellagenus0.0020.3956.6542211
Actinopolysporagenus0.0020.3955.8505195
Chromatiumgenus0.0020.3954.7480185
Chromatium weisseispecies0.0020.3954.4479185
Viridibacillus neideispecies0.0020.3853.7445170
Segetibacter aerophilusspecies0.0020.3653.7353126

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Methylobacillus glycogenesspecies0.0030.4217.91190477
Methylobacillusgenus0.0030.42203.21190496
Psychrobacter glacialisspecies0.0020.38143.2623237
Niabella aurantiacaspecies0.0020.34140.5505172
Alcanivoraxgenus0.0020.27133.436099
Isoalcanivoraxgenus0.0020.2713134995
Isoalcanivorax indicusspecies0.0020.2713134995
Niabellagenus0.0020.39122.8542211
Salidesulfovibriogenus0.0020.32117.8376120
Salidesulfovibrio brasiliensisspecies0.0020.32117.8376120
Actinopolysporagenus0.0020.39117.1505195
Deferribacter autotrophicusspecies0.0020.32115.9366116
Psychroflexusgenus0.0020.3115.2345105
Psychroflexus gondwanensisspecies0.0020.3115.2345105
Deferribactergenus0.0020.32114.9368118
Chromatiumgenus0.0020.39112.4480185
Chromatium weisseispecies0.0020.39111.9479185
Helicobacter suncusspecies0.0020.46111.6717333
Pelagicoccus croceusspecies0.0020.32110357116
Rickettsia marmionii Stenos et al. 2005species0.0020.34109.4372125

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankSymptom Median FreqOdds RatioChi2BelowAbove
Clostridium taeniosporumspecies0.0030.61211269777
Dethiosulfovibriogenus0.0040.6714.61417946
Tetragenococcus doogicusspecies0.0030.6812.61279876
Hydrocarboniphaga daqingensisspecies0.0040.729.814991078
Mycoplasmopsisgenus0.0050.729.716611199
Pediococcusgenus0.0040.757.21217913
Propionispora hippeispecies0.0050.766.814491101
Propionisporagenus0.0050.766.714481102

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

Methylobacillus glycogenesspecies0.0030.4217.91190477
Methylobacillusgenus0.0030.42203.21190496
Psychrobacter glacialisspecies0.0020.38143.2623237
Niabella aurantiacaspecies0.0020.34140.5505172
Alcanivoraxgenus0.0020.27133.436099
Isoalcanivoraxgenus0.0020.2713134995
Isoalcanivorax indicusspecies0.0020.2713134995
Niabellagenus0.0020.39122.8542211
Salidesulfovibriogenus0.0020.32117.8376120
Salidesulfovibrio brasiliensisspecies0.0020.32117.8376120
Actinopolysporagenus0.0020.39117.1505195
Deferribacter autotrophicusspecies0.0020.32115.9366116
Psychroflexusgenus0.0020.3115.2345105
Psychroflexus gondwanensisspecies0.0020.3115.2345105
Deferribactergenus0.0020.32114.9368118
Chromatiumgenus0.0020.39112.4480185
Chromatium weisseispecies0.0020.39111.9479185
Helicobacter suncusspecies0.0020.46111.6717333
Pelagicoccus croceusspecies0.0020.32110357116
Rickettsia marmionii Stenos et al. 2005species0.0020.34109.4372125

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic SpeciesImpactGood CountBad Count
Bifidobacterium breve38.64130
Bifidobacterium longum34.39120
Bifidobacterium adolescentis25.49110
Segatella copri21.7650
Akkermansia muciniphila16.19137
Lactobacillus helveticus10.857036
Bifidobacterium bifidum7.8162
Bifidobacterium catenulatum6.98140
Escherichia coli3.7980
Lactobacillus johnsonii3.745216
Bifidobacterium animalis3.5380
Pediococcus acidilactici3.333126
Enterococcus faecalis2.724726
Enterococcus durans2.315014
Enterococcus faecium1.832822
Streptococcus thermophilus1.2821
Clostridium butyricum0.92411
Limosilactobacillus reuteri0.822712
Lactococcus lactis0.2863
Leuconostoc mesenteroides0.261812
Lacticaseibacillus paracasei0.25208
Ligilactobacillus salivarius0.25165
Limosilactobacillus fermentum0.231914
Bacillus subtilis0.153729
Bifidobacterium pseudocatenulatum0.14299
Lactiplantibacillus plantarum0.1231
Limosilactobacillus vaginalis0.114336
Lactiplantibacillus pentosus0.172
Veillonella atypica0.0931
Lacticaseibacillus casei0.051110
Lactobacillus crispatus-0.021415
Lactobacillus acidophilus-0.081813
Lacticaseibacillus rhamnosus-0.128
Heyndrickxia coagulans-0.161421
Odoribacter laneus-0.402
Parabacteroides goldsteinii-0.4324
Lactobacillus jensenii-1.693630
Faecalibacterium prausnitzii-3.3914
Blautia hansenii-12.1222
Blautia wexlerae-12.4601
Bacteroides uniformis-136.4809
Bacteroides thetaiotaomicron-148.9709

Odds Ratio Snapshot: Small intestinal bacterial overgrowth (SIBO)

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01182
p < 0.001164
p < 0.0001146
p < 0.00001130

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports). IMHO using average value instead of median will often result in a worse situation for the patient

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Bacteroidesgenus31.10225.83424.21730.409
Faecalibacteriumgenus10.53112.87512.1559.178
Faecalibacterium prausnitziispecies10.19312.30111.478.958
Phocaeicola vulgatusspecies6.2835.7883.4274.247
Bacteroides uniformisspecies3.2292.711.5592.11
Ruminococcusgenus5.965.5864.3943.874
Coprococcusgenus1.3131.4360.7380.483
Clostridiumgenus2.0671.851.3591.612
Phocaeicola doreispecies3.7152.8730.4120.196
Bacteroides thetaiotaomicronspecies1.6121.0490.4630.593
Bacteroides cellulosilyticusspecies1.0920.8440.0750.179
Lachnospira pectinoschizaspecies0.5490.6680.3370.245
Ruminococcus bromiispecies0.7840.7910.1740.083
Bifidobacteriumgenus0.5740.950.1280.045
Bilophila wadsworthiaspecies0.3870.340.1990.273
Bilophilagenus0.3950.3480.2090.281
Lachnobacteriumgenus0.2220.3250.0760.028
Sutterella wadsworthensisspecies0.7110.6570.0590.011
Doreagenus0.4940.4820.2920.336
Hathewayagenus0.3810.2750.1550.198

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.

tax_nameRankIncidence Odds RatioChi2Symptoms %Reference %
Halanaerobiumgenus1.587.726.416.7

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Isoalcanivoraxgenus0.0020.2653.937198
Isoalcanivorax indicusspecies0.0020.2653.937198
Alcanivoraxgenus0.0020.2753.8382102
Niabella aurantiacaspecies0.0020.3343.2545182
Pelagicoccus croceusspecies0.0020.3240.7378122
Psychrobacter glacialisspecies0.0020.3835.8660250
Niabellagenus0.0020.3835585221
Viridibacillus neideispecies0.0020.3832.9472179
Chromatiumgenus0.0020.3932.1515200
Chromatium weisseispecies0.0020.3932514200
Sporosarcina pasteuriispecies0.0020.428.6444179
Thiorhodococcusgenus0.0020.4227.4578245
Syntrophomonas sapovoransspecies0.0020.4227536227
Sporosarcinagenus0.0020.4226.9448186
Lysinibacillusgenus0.0020.4225.9401167
Thermodesulfovibrio thiophilusspecies0.0020.4523.5540243
Oenococcusgenus0.0020.4622.6601277
Thermodesulfovibriogenus0.0020.4722.1625292
Helicobacter suncusspecies0.0020.4821.7761363
Viridibacillusgenus0.0020.517.6486242

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Lachnobacteriumgenus0.0282.0724311972474
Bifidobacterium longumspecies0.01352.14228.29001929
Paenibacillusgenus0.0030.38208.1999384
Erysipelothrixgenus0.0170.51205.722441135
Anaerobranca zavarziniispecies0.0051.98195.510462066
Anaerobrancagenus0.0051.98195.510462066
Erysipelothrix murisspecies0.0160.52191.421941135
Slackiagenus0.0091.9182.111612202
Legionella shakespeareispecies0.0030.37158.9659243
Bacteroidesgenus30.4090.57158.225111422
Faecalibacteriumgenus9.1781.76157.214232508
Niabella aurantiacaspecies0.0020.33155.3545182
Eubacterium callanderispecies0.0070.54155.218821016
Holdemaniagenus0.0270.56153.422221244
Psychrobacter glacialisspecies0.0020.38152.7660250
Bifidobacteriumgenus0.0451.73146.514132447
Methylonatrumgenus0.0040.54142.51617870
Methylonatrum kenyensespecies0.0040.54142.51617870
Amedibacillus dolichusspecies0.0220.54141.71678912
Amedibacillusgenus0.0220.54141.41677912

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankSymptom Median FreqOdds RatioChi2BelowAbove
Clostridium taeniosporumspecies0.0030.6110.21349827
Dethiosulfovibriogenus0.0040.676.715051012

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Lachnobacteriumgenus0.0282.0724311972474
Bifidobacterium longumspecies0.01352.14228.29001929
Paenibacillusgenus0.0030.38208.1999384
Erysipelothrixgenus0.0170.51205.722441135
Anaerobranca zavarziniispecies0.0051.98195.510462066
Anaerobrancagenus0.0051.98195.510462066
Erysipelothrix murisspecies0.0160.52191.421941135
Slackiagenus0.0091.9182.111612202
Legionella shakespeareispecies0.0030.37158.9659243
Bacteroidesgenus30.4090.57158.225111422
Faecalibacteriumgenus9.1781.76157.214232508
Niabella aurantiacaspecies0.0020.33155.3545182
Eubacterium callanderispecies0.0070.54155.218821016
Holdemaniagenus0.0270.56153.422221244
Psychrobacter glacialisspecies0.0020.38152.7660250
Bifidobacteriumgenus0.0451.73146.514132447
Methylonatrumgenus0.0040.54142.51617870
Methylonatrum kenyensespecies0.0040.54142.51617870
Amedibacillus dolichusspecies0.0220.54141.71678912
Amedibacillusgenus0.0220.54141.41677912

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic SpeciesImpactGood CountBad Count
Faecalibacterium prausnitzii842.75130
Blautia hansenii196.62201
Blautia wexlerae129.1980
Segatella copri96.3580
Bifidobacterium breve64.71160
Bifidobacterium longum57.42170
Bifidobacterium adolescentis42.42160
Lactobacillus helveticus39.079834
Akkermansia muciniphila23.53244
Bifidobacterium bifidum13.29112
Bifidobacterium catenulatum11.2682
Escherichia coli8.6773
Bifidobacterium animalis6.0871
Bacillus subtilis1.264438
Clostridium butyricum0.961917
Veillonella atypica0.8366
Enterococcus faecium0.762214
Enterococcus durans0.662620
Limosilactobacillus fermentum0.51223
Streptococcus thermophilus0.3223
Bifidobacterium pseudocatenulatum0.222020
Limosilactobacillus vaginalis0.133738
Lactiplantibacillus pentosus0.1361
Ligilactobacillus salivarius0.0473
Lactiplantibacillus plantarum-0.0135
Lactococcus lactis-0.0345
Lactobacillus crispatus-0.0619
Lacticaseibacillus paracasei-0.1511
Lacticaseibacillus rhamnosus-0.1736
Lactobacillus acidophilus-0.181011
Leuconostoc mesenteroides-0.19711
Lacticaseibacillus casei-0.2208
Limosilactobacillus reuteri-0.351720
Lactobacillus jensenii-0.742624
Parabacteroides goldsteinii-6.8644
Pediococcus acidilactici-9.82148
Enterococcus faecalis-17.665951
Parabacteroides distasonis-22.6904
Lactobacillus johnsonii-58.414839
Bacteroides uniformis-547.16013
Bacteroides thetaiotaomicron-585.02011

Odds Ratio Snapshot: Long COVID

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01223
p < 0.001199
p < 0.0001181
p < 0.00001164

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports). IMHO using average value instead of median will often result in a worse situation for the patient

tax_nameRankSymptom AverageReference AverageSymptom MedianReference Median
Faecalibacterium prausnitziispecies13.57512.08611.27512.554
Phocaeicola doreispecies3.4842.8540.3950.746
Roseburiagenus2.4322.8761.8121.484
Lachnospiragenus2.4242.7551.9011.631
Roseburia faecisspecies0.8551.2390.5940.378
Sutterella wadsworthensisspecies0.750.650.0490.239
Coprococcusgenus1.0831.4630.7410.609
Pedobactergenus1.2990.9710.5510.651
Blautia wexleraespecies0.4740.5890.3240.27
Anaeroplasmagenus1.1970.4320.0030.05
Doreagenus0.4540.4860.2990.256
Parabacteroides goldsteiniispecies0.5850.5690.1330.171
Thermicanusgenus0.2060.1880.1010.127
Odoribactergenus0.280.1890.1220.146
Bacteroides stercorirosorisspecies0.1660.1960.1390.116
Collinsella aerofaciensspecies0.1540.1720.050.071
Acetivibrio alkalicellulosispecies0.2370.2610.10.08
Acetivibriogenus0.2460.270.1050.085
Dorea formicigeneransspecies0.1110.1360.0860.067
Anaerofilumgenus0.230.2730.1090.092

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.

tax_nameRankIncidence Odds RatioChi2Symptoms %Reference %
Lactococcusgenus1.277.260.547.6
Sporotomaculumgenus0.728.831.643.8
Sporotomaculum syntrophicumspecies0.738.531.343.2
Enterobacter hormaecheispecies0.76.91825.8
Actinopolysporagenus0.589.910.618.2
Rothia mucilaginosaspecies0.628.311.718.8
Citrobactergenus0.657.112.519.2
Peptoniphilus lacrimalisspecies1.478.220.714.1
Chromatiumgenus0.637.311.217.6
Chromatium weisseispecies0.647.311.217.6
Anaerococcus hydrogenalisspecies1.486.916.110.9

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Isoalcanivoraxgenus0.0020.2776.737099
Isoalcanivorax indicusspecies0.0020.2776.737099
Alcanivoraxgenus0.0020.2776.6380103
Nostoc flagelliformespecies0.0020.2574.831178
Niabella aurantiacaspecies0.0020.3271.5534172
Pelagicoccus croceusspecies0.0020.366378115
Psychrobacter glacialisspecies0.0020.3665.8654233
Deferribacter autotrophicusspecies0.0020.3165.2378116
Deferribactergenus0.0020.3164.6381118
Salidesulfovibriogenus0.0020.3263.2386122
Salidesulfovibrio brasiliensisspecies0.0020.3263.2386122
Actinopolysporagenus0.0020.3660.6537192
Niabellagenus0.0020.3660.1571208
Rickettsia marmionii Stenos et al. 2005species0.0020.3360394130
Lentibacillusgenus0.0020.3657.6500181
Psychroflexusgenus0.0020.3257.5343111
Psychroflexus gondwanensisspecies0.0020.3257.5343111
Lentibacillus salinarumspecies0.0020.3657.2485175
Viridibacillus neideispecies0.0020.3656.6463166
Bacillus ferrariarumspecies0.0020.3456.1361121

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Actinopolysporagenus0.0030.16326.3628101
Nostocgenus0.0030.33281.51134376
Flammeovirgagenus0.0030.35186.1742261
Asticcacaulisgenus0.0030.42185.91064446
Flammeovirga pacificaspecies0.0030.35185.6741261
Planococcusgenus0.0030.32182.4613194
Planococcus columbaespecies0.0030.31176.2575179
Streptococcus oralisspecies0.0030.48167.31358652
Psychrobacter glacialisspecies0.0020.36164.8654233
Niabella aurantiacaspecies0.0020.32158.7534172
Clostridium tepidiprofundispecies0.0030.38152.9659248
Niabellagenus0.0020.36142.4571208
Alcanivoraxgenus0.0020.27142.3380103
Isoalcanivoraxgenus0.0020.27140.737099
Isoalcanivorax indicusspecies0.0020.27140.737099
Atopobium fossorspecies0.0030.37138.2555203
Lentibacillusgenus0.0020.36128.3500181
Nostoc flagelliformespecies0.0020.25127.531178
Desulfitobacteriumgenus0.0050.38126.8525197
Lentibacillus salinarumspecies0.0020.36125.5485175

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankSymptom Median FreqOdds RatioChi2BelowAbove
Clostridium taeniosporumspecies0.0030.6217.51284800
Dethiosulfovibriogenus0.0040.6712.71433961
Tetragenococcus doogicusspecies0.0030.6811.81289875
Mycoplasmopsisgenus0.0050.71017071203
Hydrocarboniphaga daqingensisspecies0.0040.72915331097
Tetragenococcusgenus0.0030.746.81270946
Pediococcusgenus0.0040.756.61239926

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Actinopolysporagenus0.0030.16326.3628101
Nostocgenus0.0030.33281.51134376
Flammeovirgagenus0.0030.35186.1742261
Asticcacaulisgenus0.0030.42185.91064446
Flammeovirga pacificaspecies0.0030.35185.6741261
Planococcusgenus0.0030.32182.4613194
Planococcus columbaespecies0.0030.31176.2575179
Streptococcus oralisspecies0.0030.48167.31358652
Psychrobacter glacialisspecies0.0020.36164.8654233
Niabella aurantiacaspecies0.0020.32158.7534172
Clostridium tepidiprofundispecies0.0030.38152.9659248
Niabellagenus0.0020.36142.4571208
Alcanivoraxgenus0.0020.27142.3380103
Isoalcanivoraxgenus0.0020.27140.737099
Isoalcanivorax indicusspecies0.0020.27140.737099
Atopobium fossorspecies0.0030.37138.2555203
Lentibacillusgenus0.0020.36128.3500181
Nostoc flagelliformespecies0.0020.25127.531178
Desulfitobacteriumgenus0.0050.38126.8525197
Lentibacillus salinarumspecies0.0020.36125.5485175

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Blautia hansenii194.64190
Blautia wexlerae147.3880
Faecalibacterium prausnitzii74.57103
Enterococcus faecalis19.483444
Lactobacillus johnsonii9.372962
Streptococcus thermophilus4.180
Escherichia coli3.3582
Segatella copri2.8324
Enterococcus faecium2.161045
Bifidobacterium breve1.9123
Heyndrickxia coagulans1.89739
Bifidobacterium longum1.722
Bifidobacterium adolescentis1.4620
Enterococcus durans1.42730
Bifidobacterium bifidum0.4832
Bifidobacterium catenulatum0.2734
Lacticaseibacillus paracasei0.2514
Bifidobacterium animalis0.1611
Leuconostoc mesenteroides0.091126
Limosilactobacillus fermentum0.04929
Veillonella atypica-0.0324
Ligilactobacillus salivarius-0.11521
Lacticaseibacillus casei-0.13112
Lacticaseibacillus rhamnosus-0.23114
Lactiplantibacillus plantarum-0.26012
Limosilactobacillus reuteri-0.472431
Akkermansia muciniphila-0.51315
Lactobacillus acidophilus-0.7542
Lactobacillus crispatus-0.95143
Odoribacter laneus-0.9603
Bacillus subtilis-0.992955
Limosilactobacillus vaginalis-1.332170
Parabacteroides distasonis-1.3501
Bacteroides uniformis-2.433
Lactobacillus jensenii-2.56682
Bifidobacterium pseudocatenulatum-3.11543
Lactobacillus helveticus-5.0535100
Bacteroides thetaiotaomicron-5.1723
Clostridium butyricum-5.21035
Pediococcus acidilactici-9.294051
Parabacteroides goldsteinii-9.3012

Odds Ratio Snapshot: Official Diagnosis: Mast Cell Dysfunction

Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?. Self-described: Official Diagnosis: Mast Cell Dysfunction​

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01131
p < 0.001118
p < 0.0001106
p < 0.0000194

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at the bacterua below, we see that for some the average is above and the median below. Should one increase or decrease this bacteria?

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).
IMHO using average value instead of median will often result in a worse situation for the patient

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Phocaeicola doreispecies4.4642.8720.3990.92
Roseburiagenus3.0652.8331.7862.058
Sutterellagenus1.7111.6431.2591.022
Parabacteroides merdaespecies0.5580.750.3060.09
Clostridiumgenus1.9771.8561.3631.566
Bacteroides thetaiotaomicronspecies1.7541.0570.4640.659
Coprococcusgenus1.2711.4350.730.597
Mediterraneibactergenus1.1740.7060.2790.386
Bacteroides caccaespecies1.4510.8640.290.19
Bacteroides cellulosilyticusspecies1.260.8450.0760.158
Lachnospira pectinoschizaspecies0.670.6630.3340.257
Blautia obeumspecies0.5930.5720.2330.303
Bilophilagenus0.3630.350.2110.272
Hathewaya histolyticaspecies0.4260.2750.1560.205
Hathewayagenus0.4270.2760.1560.205
Sutterella wadsworthensisspecies0.8450.6550.0580.011
Veillonella cricetispecies0.2790.2370.1240.168
Bacteroides rodentiumspecies0.3380.3930.1870.231
Akkermansiagenus1.5821.3530.0530.011
Akkermansia muciniphilaspecies1.5821.3540.0530.011

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing.

Nothing found that was significant

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Sulfobacillus acidophilusspecies0.0020.3910.88433
Sulfobacillusgenus0.0020.3910.88433
Caldanaerobacter hydrothermalisspecies0.0020.439.89641
Caldanaerobactergenus0.0020.439.89641
Desulfotomaculum defluviispecies0.0030.568.11032578
Pelagicoccusgenus0.0020.577.4859490
Alkalibacteriumgenus0.0030.577.4907518
Hydrogenophilusgenus0.0030.587.31162670
Sporotomaculum syntrophicumspecies0.0030.596.81138668

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Nostocgenus0.0030.34295.71214408
Bacillusgenus0.0060.43277.11954837
Erysipelothrixgenus0.0180.47250.123461111
Psychrobactergenus0.0030.39239.81254492
Sharpeagenus0.0250.42331278514
Methylobacillus glycogenesspecies0.0030.4232.71286519
Sharpea azabuensisspecies0.0250.41226.81264514
Methylobacillusgenus0.0030.42219.31287537
Erysipelothrix murisspecies0.0170.5218.722741130
Candidatus Tammella caduceiaespecies0.0030.41205.71155478
Paenibacillusgenus0.0030.39205.31016398
Candidatus Tammellagenus0.0030.42200.11170494
[Ruminococcus] torquesspecies0.040.51189.31921971
Holdemaniagenus0.0280.5318723151225
Streptococcus oralisspecies0.0030.47185.81453686
Amedibacillus dolichusspecies0.0240.5184.41759879
Amedibacillusgenus0.0240.51841758879
Haemophilus parainfluenzaespecies0.011.91173.710231952
Haemophilusgenus0.011.89170.310351959
Luteolibactergenus0.0150.46169.71177541

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

Nothing found that was significant

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Nostocgenus0.0030.34295.71214408
Bacillusgenus0.0060.43277.11954837
Erysipelothrixgenus0.0180.47250.123461111
Psychrobactergenus0.0030.39239.81254492
Sharpeagenus0.0250.42331278514
Methylobacillus glycogenesspecies0.0030.4232.71286519
Sharpea azabuensisspecies0.0250.41226.81264514
Methylobacillusgenus0.0030.42219.31287537
Erysipelothrix murisspecies0.0170.5218.722741130
Candidatus Tammella caduceiaespecies0.0030.41205.71155478
Paenibacillusgenus0.0030.39205.31016398
Candidatus Tammellagenus0.0030.42200.11170494
[Ruminococcus] torquesspecies0.040.51189.31921971
Holdemaniagenus0.0280.5318723151225
Streptococcus oralisspecies0.0030.47185.81453686
Amedibacillus dolichusspecies0.0240.5184.41759879
Amedibacillusgenus0.0240.51841758879
Haemophilus parainfluenzaespecies0.011.91173.710231952
Haemophilusgenus0.011.89170.310351959
Luteolibactergenus0.0150.46169.71177541

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors
Probiotic SpeciesImpactGood CountBad Count
Akkermansia muciniphila36.08186
Segatella copri32.7252
Bifidobacterium breve21.3185
Bifidobacterium longum19.0686
Bifidobacterium adolescentis14.3887
Lactobacillus helveticus9.114827
Streptococcus thermophilus7.9782
Lactobacillus johnsonii7.282226
Bifidobacterium bifidum4.3572
Bifidobacterium catenulatum4.2480
Parabacteroides goldsteinii4.1159
Bifidobacterium animalis1.9770
Lactococcus lactis1.162
Veillonella atypica1.02113
Clostridium butyricum0.9779
Limosilactobacillus vaginalis0.862029
Odoribacter laneus0.7620
Enterococcus durans0.71120
Limosilactobacillus fermentum0.11215
Leuconostoc mesenteroides-0.0737
Lacticaseibacillus paracasei-0.0729
Lacticaseibacillus rhamnosus-0.0902
Bifidobacterium pseudocatenulatum-0.156
Heyndrickxia coagulans-0.139
Ligilactobacillus salivarius-0.1416
Lactobacillus crispatus-0.1537
Lactiplantibacillus plantarum-0.1904
Lactiplantibacillus pentosus-0.2104
Lacticaseibacillus casei-0.2107
Lactobacillus acidophilus-0.22812
Bacillus subtilis-0.26827
Limosilactobacillus reuteri-0.42516
Lactobacillus jensenii-1.411529
Pediococcus acidilactici-1.861732
Enterococcus faecium-2.58722
Enterococcus faecalis-9.412850
Parabacteroides distasonis-9.594
Blautia wexlerae-13.313
Escherichia coli-24.86112
Blautia hansenii-26.6576
Faecalibacterium prausnitzii-116.8333
Bacteroides uniformis-167.73111
Bacteroides thetaiotaomicron-178.11111

Comments on this Condition

Two of the above sections reported nothing significant found. This implies that the microbiome plays a secondary role. The bacteria shifts are more likely consequences of the condition than triggers of the condition. Regardless, there is a potential that the above probiotics may modify the severity of the condition.

It is unclear if the shifts are due to anti-histamine and other drugs usage.

Odds Ratio Snapshot: Depression

This document presents the results of statistical analysis on symptoms from viable, self-annotated Biomesight microbiome samples. The methodology for data acquisition is outlined in New Standards for Microbiome Analysis?.

Tables have been refined to display only genus- and species-level taxa, the 20 most prominent entries per group, and associations achieving statistical significance (P < 0.01).

The following sections provide the processed data, accompanied by guidance on interpretation and application. Counts of significant bacterial taxa are included, reflecting the application of non-standard but rigorously validated statistical approaches to extensive sample and reference populations, where statistical power derives from dataset scale.

SignificanceGenus
p < 0.01196
p < 0.001172
p < 0.0001154
p < 0.00001140

Averages and Medians

I prefer medians over averages. Medians are the values where half of the people have less and half has more. If the data was a bell-curve, then the values will almost be the same… with bacteria that happens rarely. Look at Bifidobacterium below, we see that the average is above and the median below.

If symptom median is higher than reference median, it means there is more of this bacteria. If lower, then less. This ignores how often the bacteria is seen (we average only over reports).

tax_nameRankSymptom AvarageReference AverageSymptom MedianReference Median
Bacteroidesgenus28.80225.92624.22427.059
Phocaeicolagenus12.35710.7869.31411.306
Phocaeicola vulgatusspecies7.0435.7513.3944.929
Bacteroides uniformisspecies2.9092.7231.5531.958
Bacteroides thetaiotaomicronspecies1.2341.0650.4580.734
Coprococcusgenus1.231.440.7370.552
Roseburia faecisspecies0.9691.2170.5770.455
Bilophilagenus0.4170.3470.2070.319
Bifidobacteriumgenus0.5340.9530.1310.035
Bacteroides stercorisspecies2.0661.5430.0330.123
Blautia coccoidesspecies0.7760.9170.5920.504
Bilophila wadsworthiaspecies0.3950.3390.1970.281
Mediterraneibactergenus0.8850.7080.2780.326
Butyricimonasgenus0.2170.1860.1080.154
Hathewayagenus0.3140.2770.1550.201
Hathewaya histolyticaspecies0.3140.2770.1550.201
Bacteroides rodentiumspecies0.4350.390.1860.231
Bifidobacterium longumspecies0.2370.3260.0510.012
Lachnobacteriumgenus0.1970.3270.0750.041
Bacteroides stercorirosorisspecies0.2340.1910.1350.164

Bacteria Incidence – How often is it reported

The common sense belief is that if a bacteria is reported more often, then the amount should be higher. This is often not true. The microbiome is a complex thing. Look at Bacteroides uniformis below, we see that the average is above and the median below

tax_nameRankIncidence Odds RatioChi2Symptoms %Reference %
Bifidobacterium brevespecies0.647.826.641.4
Anaerococcus hydrogenalisspecies1.667.218.211

More or Less often based on Symptom Median All Incidence

This is a little more complex to understand. If we compute the mid point for people with the symptom, then if the bacteria was not involved then half of the reference should be above this value and half below this value. If not, it means that the symptom tends to over or under growth.

tax_nameRankSymptom MedianOdds RatioChi2BelowAbove
Niabella aurantiacaspecies0.0020.3444.3544183
Psychroflexusgenus0.0020.3143.7357111
Psychroflexus gondwanensisspecies0.0020.3143.7357111
Rickettsia marmionii Stenos et al. 2005species0.0020.3341.6398131
Psychrobacter glacialisspecies0.0020.3738.6660246
Niabellagenus0.0020.3836584222
Chromatiumgenus0.0020.3834.4517198
Chromatium weisseispecies0.0020.3834.2516198
Lentibacillusgenus0.0020.3834510196
Lentibacillus salinarumspecies0.0020.3833.7494190
Viridibacillus neideispecies0.0020.3833.3469180
Thermoanaerobacteriumgenus0.0020.4130483196
Thiomicrospiragenus0.0020.3929.3335130
Sporosarcina pasteuriispecies0.0020.4129.2439178
Thiorhodococcusgenus0.0020.4229.1578243
Thermoanaerobacterium islandicumspecies0.0020.4129476196
Syntrophomonas sapovoransspecies0.0020.4229534223
Sporosarcinagenus0.0020.4227.5443185
Thermodesulfovibrio thiophilusspecies0.0020.4425.5536237
Oenococcusgenus0.0020.4524.8604273

More or Less often based on Reference Median All Incidence

This is like the above, but with a different line in the sand. Instead of the median of those with the condition, we use the median of the reference set.

tax_nameRankReference MedianOdds RatioChi2BelowAbove
Bifidobacterium longumspecies0.0122.27260.28701971
Bifidobacteriumgenus0.0352.04241.712662586
Methylobacillus glycogenesspecies0.0030.4232.51250497
Methylobacillusgenus0.0030.41217.21249516
Corynebacteriumgenus0.00850.42201.91163486
Bilophilagenus0.31850.55162.822471236
Erysipelothrix murisspecies0.0150.5516121531179
Psychrobacter glacialisspecies0.0020.37156.5660246
Niabella aurantiacaspecies0.0020.34153.5544183
Methylonatrumgenus0.0040.53145.21620866
Methylonatrum kenyensespecies0.0040.53145.21620866
Catonella morbispecies0.010.5614419681099
Catonellagenus0.010.56141.419661104
Erysipelothrixgenus0.01550.57139.921511232
Niabellagenus0.0020.38137584222
Megasphaera elsdeniispecies0.00450.41132.7640260
Bacteroides thetaiotaomicronspecies0.7340.6130.123891422
Veillonella parvulaspecies0.0031.9128.66661266
Alkalithermobacter paradoxusspecies0.0040.55125.81537853
Odoribacter denticanisspecies0.0050.57124.11642928

More or Less often based on Symptom Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankSymptom Median FreqOdds RatioChi2BelowAbove
Clostridium taeniosporumspecies0.0030.6111.21344814
Dethiosulfovibriogenus0.0040.667.61500994
Tetragenococcus doogicusspecies0.0030.677.21360910

More or Less often based on Reference Median High Incidence

Above we see that many of the top bacteria identified are sparse, that is not reported often. We then restrict them to those that occur above 50% or the time.

tax_nameRankReference Median FreqOdds RatioChi2BelowAbove
Bifidobacterium longumspecies0.0122.27260.28701971
Bifidobacteriumgenus0.0352.04241.712662586
Methylobacillus glycogenesspecies0.0030.4232.51250497
Methylobacillusgenus0.0030.41217.21249516
Corynebacteriumgenus0.00850.42201.91163486
Bilophilagenus0.31850.55162.822471236
Erysipelothrix murisspecies0.0150.5516121531179
Psychrobacter glacialisspecies0.0020.37156.5660246
Niabella aurantiacaspecies0.0020.34153.5544183
Methylonatrumgenus0.0040.53145.21620866
Methylonatrum kenyensespecies0.0040.53145.21620866
Catonella morbispecies0.010.5614419681099
Catonellagenus0.010.56141.419661104
Erysipelothrixgenus0.01550.57139.921511232
Niabellagenus0.0020.38137584222
Megasphaera elsdeniispecies0.00450.41132.7640260
Bacteroides thetaiotaomicronspecies0.7340.6130.123891422
Veillonella parvulaspecies0.0031.9128.66661266
Alkalithermobacter paradoxusspecies0.0040.55125.81537853
Odoribacter denticanisspecies0.0050.57124.11642928

Summary

A large number of bacterial taxa exhibit shifts with P < 0.01 in association with this condition. The subsequent challenge is determining how to modulate these taxa, since the volume of candidates exceeds what most individuals can practically consider. Moreover, for many of the taxa identified, there is no published evidence in the U.S. National Library of Medicine describing how to alter their abundance.

A deep optimization model, such as the one implemented on the Microbiome Taxa R2 site, can be used to inform probiotic selection. This model provides coverage for each identified taxon and infers which probiotics are most likely to shift their levels. Its output may then be integrated with more conventional recommendations derived from literature indexed in the U.S. National Library of Medicine where such evidence exists, with the two recommendation sets reconciled by giving priority to probiotic-based suggestions.

Development of a dedicated database based on Biomesight samples is in progress. The current model uses data contributed by PrecisionBiome, and datasets generated with differing laboratory processing pipelines cannot be safely combined, as discussed in The taxonomy nightmare before Christmas…. Once the Biomesight-specific database is complete, an option for generating (offline-only) personalized suggestions will be added to the Microbiome Prescription website.

Probiotics Suggestions

The following are based on a simplified algorithm using R2 data for Biomesight. These are tentative numbers subject to future refinements. Bacteria listed are only for probiotics detected with Biomesight tests. Probiotics include some that are available only in some countries and some that are pending approval for retail sale.

  • Good Count: Number of bacteria expected to shift in desired direction
  • Bad Count: Number of bacteria expected to shift in wrong direction
  • Impact: Estimator of impact based on Chi-2, Slope and R2 vectors

Some literature suggesting that the model’s suggestions are reasonable:

  • Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse. Neuropharmacology (Neuropharmacology ) Vol: 229 Issue: Pages: 109480 Pub: 2023 May 15 ePub: 2023 Mar 1 Authors Sushma G,Vaidya B,Sharma S,Devabattula G,Bishnoi M,Kondepudi KK,Sharma SS
  • Heat-sterilized Bifidobacterium breve prevents depression-like behavior and interleukin-1ß expression in mice exposed to chronic social defeat stress. Brain, behavior, and immunity (Brain Behav Immun ) Vol: Issue: Pages: Pub: 2021 May 29 ePub: 2021 May 29 Authors Kosuge A,Kunisawa K,Arai S,Sugawara Y,Shinohara K,Iida T,Wulaer B,Kawai T,Fujigaki H,Yamamoto Y,Saito K,Nabeshima T,Mouri A
  • Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway.
    Frontiers in nutrition (Front Nutr ) Vol: 12 Issue: Pages: 1529566 Pub: 2025 ePub: 2025 Jan 30 Authors Pan Y,Huang Q,Liang Y,Xie Y,Tan F,Long X
  • Lipid and Energy Metabolism of the Gut Microbiota Is Associated with the Response to Probiotic Bifidobacterium breve Strain for Anxiety and Depressive Symptoms in Schizophrenia.
    Journal of personalized medicine (J Pers Med ) Vol: 11 Issue: 10 Pages: Pub: 2021 Sep 30 ePub: 2021 Sep 30 Authors Yamamura R,Okubo R,Katsumata N,Odamaki T,Hashimoto N,Kusumi I,Xiao J,Matsuoka YJ
  • Towards a psychobiotic therapy for depression: Bifidobacterium breve CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice. Neurobiology of stress (Neurobiol Stress ) Vol: 12 Issue: Pages: 100216 Pub: 2020 May ePub: 2020 Mar 20 Authors Tian P,O’Riordan KJ,Lee YK,Wang G,Zhao J,Zhang H,Cryan JF,Chen W
Probiotic SpeciesImpactGood CountBad Count
Faecalibacterium prausnitzii256.6280
Blautia hansenii181.61221
Bifidobacterium breve89.17150
Bifidobacterium longum79.15152
Blautia wexlerae59.8870
Bifidobacterium adolescentis58.57142
Segatella copri41.7930
Bifidobacterium bifidum17.98112
Bifidobacterium catenulatum15.5780
Escherichia coli14.66110
Enterococcus faecalis14.274246
Akkermansia muciniphila11.57129
Lactobacillus helveticus9.864353
Bifidobacterium animalis8.1770
Enterococcus faecium5.051434
Streptococcus thermophilus2.340
Enterococcus durans2.142523
Veillonella atypica1.34120
Clostridium butyricum0.671326
Bacillus subtilis0.512833
Lacticaseibacillus paracasei0.23135
Lactococcus lactis0.1525
Limosilactobacillus fermentum0.121017
Lactiplantibacillus pentosus0.164
Heyndrickxia coagulans0.04814
Ligilactobacillus salivarius-0.05210
Lactiplantibacillus plantarum-0.0836
Lacticaseibacillus casei-0.17110
Lacticaseibacillus rhamnosus-0.1825
Limosilactobacillus vaginalis-0.222551
Leuconostoc mesenteroides-0.26413
Bifidobacterium pseudocatenulatum-0.35724
Lactobacillus crispatus-0.63231
Limosilactobacillus reuteri-0.781722
Lactobacillus acidophilus-0.83533
Odoribacter laneus-1.7803
Lactobacillus jensenii-3.231855
Pediococcus acidilactici-7.222633
Lactobacillus johnsonii-13.523639
Parabacteroides goldsteinii-21.27013
Parabacteroides distasonis-27.34011
Bacteroides uniformis-285.55011
Bacteroides thetaiotaomicron-294.72010